Cancer

INDICATION: Bladder cancer; breast cancer; colorectal cancer; melanoma; sarcoma

Mouse studies suggest inhibiting DDR2 could enhance the efficacy of anti-PD-1 therapies

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE